Bexarotene (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bexarotene" in Vietnamese language version.

refsWebsite
Global rank Vietnamese rank
4th place
7th place
2nd place
2nd place
1st place
1st place
6th place
4th place
8,869th place
6,021st place
low place
low place
3,823rd place
5,469th place
719th place
1,344th place
low place
low place
low place
2,650th place
low place
low place
399th place
214th place
68th place
114th place
8,255th place
low place
3,011th place
3,239th place

aacrjournals.org

clincancerres.aacrjournals.org

archive.org

  • Gniadecki, R; Assaf, C; Bagot, M; Dummer, R; Duvic, M; Knobler, R; Ranki, A; Schwandt, P; Whittaker, S (2007). “The optimal use of bexarotene in cutaneous T-cell lymphoma”. British Journal of Dermatology. 157 (3): 433–40. doi:10.1111/j.1365-2133.2007.07975.x. PMID 17553039.
  • Rowe, A (tháng 2 năm 1997). “Retinoid X receptors”. The International Journal of Biochemistry & Cell Biology. 29 (2): 275–278. doi:10.1016/S1357-2725(96)00101-X. PMID 9147128.

ascopubs.org

jco.ascopubs.org

doi.org

drugs.com

europa.eu

ema.europa.eu

lclabs.com

medcitynews.com

medicalnewstoday.com

medicalxpress.com

medicines.org.uk

medscape.com

reference.medscape.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Gniadecki, R; Assaf, C; Bagot, M; Dummer, R; Duvic, M; Knobler, R; Ranki, A; Schwandt, P; Whittaker, S (2007). “The optimal use of bexarotene in cutaneous T-cell lymphoma”. British Journal of Dermatology. 157 (3): 433–40. doi:10.1111/j.1365-2133.2007.07975.x. PMID 17553039.
  • Dragnev, KH; Petty, WJ; Shah, SJ; Lewis, LD; Black, CC; Memoli, V; Nugent, WC; Hermann, T; Negro-Vilar, A (2007). “A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer” (PDF). Clinical Cancer Research. 13 (6): 1794–800. doi:10.1158/1078-0432.CCR-06-1836. PMID 17363535.
  • Esteva, FJ; Glaspy, J; Baidas, S; Laufman, L; Hutchins, L; Dickler, M; Tripathy, D; Cohen, R; DeMichele, A (tháng 3 năm 2003). “Multicenter Phase II Study of Oral Bexarotene for Patients With Metastatic Breast Cancer” (PDF). Journal of Clinical Oncology. 21 (6): 999–1006. doi:10.1200/JCO.2003.05.068. PMID 12637463.
  • Rowe, A (tháng 2 năm 1997). “Retinoid X receptors”. The International Journal of Biochemistry & Cell Biology. 29 (2): 275–278. doi:10.1016/S1357-2725(96)00101-X. PMID 9147128.
  • Dawson, M. I.; Xia, Z. (2012). “The retinoid X receptors and their ligands”. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1821 (1): 21–56. doi:10.1016/j.bbalip.2011.09.014. PMC 4097889. PMID 22020178.
  • Qu, L; Tang, X (tháng 1 năm 2010). “Bexarotene: a promising anticancer agent”. Cancer Chemotherapy and Pharmacology. 65 (2): 201–205. doi:10.1007/s00280-009-1140-4. PMID 19777233.
  • Cramer, P. E.; Cirrito, J. R.; Wesson, D. W.; Lee, C. Y. D.; Karlo, J. C.; Zinn, A. E.; Casali, B. T.; Restivo, J. L.; và đồng nghiệp (2012). “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”. Science. 335 (6075): 1503–1506. doi:10.1126/science.1217697. PMC 3651582. PMID 22323736.

ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

sri.com

web.archive.org